Harte Hanks (HHS) Cost of Revenue (2019 - 2026)

Harte Hanks (HHS) has 8 years of Cost of Revenue data on file, last reported at $11.3 million in Q1 2026.

• Cost of Revenue for Q1 2026 came in at $11.3 million, down 19.34% year-over-year; the trailing twelve-month figure through Mar 2026 was $47.2 million (down 17.16% YoY), and the FY2025 annual result was $49.9 million, down 11.91% from the prior year.
• Cost of Revenue slipped to $11.3 million in Q1 2026 per HHS's latest filing, from $11.7 million in the prior quarter.
• Over five years, Cost of Revenue peaked at $19.5 million in Q4 2022 and troughed at $11.3 million in Q1 2026.
• A 5-year average of $14.1 million and a median of $13.8 million in 2024 frame the typical range for Cost of Revenue.
• The sharpest annual moves came in 2022 and 2025: Cost of Revenue soared 35.73% in 2022, then decreased 20.8% in 2025.
• A 5-year view of Cost of Revenue shows it stood at $19.5 million in 2022, then dropped by 15.98% to $16.4 million in 2023, then slipped by 9.85% to $14.8 million in 2024, then retreated by 20.8% to $11.7 million in 2025, then slipped by 3.23% to $11.3 million in 2026.
• Business Quant data shows HHS's Cost of Revenue at $11.3 million in Q1 2026, $11.7 million in Q4 2025, and $11.7 million in Q3 2025.